Participant centred trials: reducing burden as a moral obligation
Emma Law makes the case for the moral contract that should sit at the heart of every clinical trial.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Emma Law makes the case for the moral contract that should sit at the heart of every clinical trial.
Protas senior team share what they want to see change in clinical trials this year.
Monique Morar shares her transition into trial management and what her background in nursing brings.
Jen Dumbleton explores novel ways to improve the success rate of large RCTs.
Protas colleagues have published a new article exploring what COVID-19 taught us about improving clinical trial design.
Jen Dumbleton talks about her role at Protas and our mission to create smarter, better trials.
Emma Law, Head of Clinical Quality Assurance, writes for The Research Quality Association (RQA).
Working in our IT Team, Kieran Hamilton shares how Protas is making use of data and tech.
Nick Medhurst shares the Good Clinical Trials Collaborative’s work and vision.
Prof Sir Martin Landray writes about how clinical trials are key to common disease prevention, early detection and treatment.
As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the pressing need to transform clinical…
Abbie Gerard shares what motivated her to move from academia to a new not-for-profit.